![](https://www.mitacs.ca/wp-content/uploads/2023/12/generic-logo-background.png)
This project is to use genetic engineered cold-sore virus to treat prostate cancer. The virus is engineered to reduce its toxicity to normal tissues but can specifically attack and kill tumour cells. Meanwhile, the virus releases a group of anti-tumour immune stimulating factors to activate immune system to eliminate prostate tumour. This project will use […]
Read More